Heaney, Christopher

Public Health - Environmental Health Science

Field development and validation of a salivary hepatitis E assay in Bangladesh

Hepatitis E virus (HEV) is the leading global cause of acute viral hepatitis; particularly in South Asia where seasonal floods contaminate drinking water supplies leading to frequent hepatitis E (HE) epidemics. Whereas case-fatality rates in the general population can vary from 0.1-3.0%, elevated mortality (10-40%) in pregnant women infected with HEV genotype 1 has been demonstrated consistently in South Asia. Current methods to confirm infection rely on enzyme immunoassays (EIA) for detection of IgM or IgG antibodies to HEV (anti-HEV) in serum or PCR of HEV RNA in serum or stool. Collection of blood and stool is invasive and suffers practical constraints in children under 5 and pregnant women in resource-limited settings which may impede the ability to make frequent follow-up measurements in epidemiologic studies. This research will serve three purposes. First, to optimize and validate an HEV salivary EIA by evaluating the sensitivity, specificity, and reliability of HEV EIAs in de-identified paired saliva and finger-stick blood samples from patients at Dhaka Shishu Hospital, Dhaka, Bangladesh an area where HEV is endemic. Second, to evaluate the acceptance, usability, and reliability of a saliva self-sampling protocol via a brief survey after patients self-sample saliva. And third, to advance efforts to integrate the optimized HEV salivary EIA into ongoing and future epidemiologic studies which would refine understanding of the time windows of seroconversion and progression of infectious vs subclinical HE symptoms. Future studies building on this pilot research will improve the scientific evidence base about the time windows of HEV exposure and infection in populations with unique susceptibility.

Douglas Granger, SON; Barbara Detrick, SOM, Pathology

People

Joanne Katz, ScD MS,BSc

Associate Chair, Director of Academic Programs

Stefan Baral, MD MPH,MBA,MSc

Director, Key Populations Program

Robert Bollinger Jr., MD MPH

Director, Johns Hopkins Center for Clinical Global Health Education (CCGHE); Associate Director, Johns Hopkins Center for Global...

Yukari C. Manabe, MD

Associate Director of Global Health Research and Innovation

Noreen Hynes, MD MPH

Director, Geographic Medicine Center of the Division of Infectious Diseases

Caitlin Kennedy, PhD MPH,BA

Co-Director, MPH concentration in Social and Behavioral Sciences in Public Health; Associate Director, Center for Qualitative...
«

October 2017

»
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
·
·
·
·

Projects

Building an Enabling Environment for Vaccines in India...

This project, now in its second phase, aims to create an enabling environment for vaccines in India and contribute to...

Read More

Mpilonhle

Mpilonhle brings multi-dimensional services to adolescents in rural South Africa. Its objective is to reduce the very high...

Read More

Nutrition Innovation Lab

"Poshan", which means good nutrition in Nepali is ongoing research that involves two interlinked large-scale research studies...

Read More

Identification and Enumeration of Pathogens in Drinking...

CWH researchers are using polymerase chain reaction and mass spectrometry technologies to develop a microbial isolation and...

Read More

Vaccine Implementation Technical Assistance Consortium

The Vaccine Implementation Technical Assistance Consortium (VITAC) - a collaboration of PATH, CDC, and IVAC - supports the...

Read More